Find policies, billing codes, payers, states, and providers
CPT 95911: Nerve Conduction Studies, 9-10 Tests
CPT code 95911 represents a diagnostic nerve conduction study comprising nine to ten nerve conduction tests. These studies measure the electrical conduction of motor and sensory peripheral nerves and are important for diagnosing conditions such as entrapment neuropathies and other neuromuscular disorders. Nationally, nerve conduction studies are a common component of electrodiagnostic evaluations and influence diagnostic pathways, specialist utilization, and episodic care for patients with suspected peripheral neuropathies.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for CPT code 95911, comparisons with closely related codes such as 95910 and 95912, and operational considerations relevant to billing and coding workflows. The publication also summarizes common modifiers and provider specialties associated with the service, typical sites of service, and common ICD-10 diagnoses linked to nerve conduction testing.
This summary is intended for a national audience of clinicians, coding professionals, and payor policy analysts seeking a clear reference on the purpose and billing context of CPT code 95911. The content focuses on clinical definition, coding relationships, and practical metadata without state-specific policy details.
Customize your policy alerts
Sign up for cpt 95911 policy alerts
Get alerted when payer policies referencing 95911 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 95911 describes a diagnostic nerve conduction study in which the provider performs nine or ten nerve conduction studies to evaluate the electrical conduction function of motor and sensory nerves. This procedure is used to assess peripheral nerve function and to help diagnose neuromuscular disorders.
-
Service type: Diagnostic nerve conduction study
-
Typical site of service: Outpatient clinic or hospital-based electrodiagnostic laboratory where nerve conduction studies are performed on limbs and peripheral nerves
National Reimbursement Benchmarks
Commercial averages sit well above Medicare: Blue Cross Blue Shield, Cigna, Aetna, UnitedHealth Group and BUCA all have mean commercial rates notably higher than Medicare’s mean of $152.20; BUCA’s mean of $256.00 in particular is roughly $103.80 above Medicare, highlighting a wide gulf between Medicare payment levels and commercial average contracting for CPT 95911. Dispersion across payers varies: range (P75–P25) calculations show Blue Cross Blue Shield at $97.70, UnitedHealth Group at $162.30, Cigna at $163.60, Aetna at $132.00, and BUCA at $121.90. Cigna and UnitedHealth Group display the widest interquartile spreads (~$163), indicating greater variability in commercial reimbursed rates, while Blue Cross Blue Shield is the tightest at $97.70, suggesting comparatively concentrated commercial pricing.